Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
11. Tesofensine (NS 2330)[1] Tesofensine---[1] 6
2ACT-293987 (NS-304)----[1] 86
3Active topical NS2 1% dermatologic cream----[1] 160
4BARDOXOLONE METHYL, CDDO-Me, CDDO-Methyl Ester, NSC 713200, Chemical Name: Oleana-1,9(11)-dien-28-oic acid, 2-cyano-3,12-dioxo-, methyl ester[2] Bardoxolone,
Bardoxolone methyl		[2] D09584 ,
D09585 		--[1] 86
5Ch11-1F4 (NSC-711516)----[1] 28
6Corticosteroid or NSAID----[1] 46
7Ips-nsc cells----[1] 6
8Non-steroidal anti-inflammatory drug (NSAID)----[1] 46
9Non-steroidal anti-inflammatory drugs (NSAIDs)----[1] 107
10Norovirus -specific T-cell (NST) therapy----[1] 65
11NS----[1] 2
12NS 2330----[1] 6
13NS-065/NCNP-01----[1] 113
14NS-089/NCNP-02----[1] 113
15NS-304----[3] 70, 86, 88
16NS-304 Placebo----[2] 70, 88
17NS2----[1] 160
18NS2330----[1] 6
19NSAID----[1] 271
20NSAIDs----[4] 46, 70, 107, 271
21NSAIDs (permitted,not necessary)----[1] 46
22NSAIDs and sulfasalazine[1] Sulfasalazine[1] D00448 --[1] 271
23NsNSAIDs----[2] 107, 271
24NSP001----[1] 96
25Other Non Steroidal Anti-Inflammatory Drugs (NSAIDs) except etodolac[1] Etodolac[1] D00315 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
26Other Non-selective NSAIDs----[1] 271
27Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses----[1] 46
28Plantain NSP----[1] 96
29Recombinant human heparan Nsulfatase (rhHNS)----[1] 19
30Satralizumab (120 mg/PFS with NSD)[1] Satralizumab[1] D11079 [1] IL6R 💬[12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 13
31Selexipag, ACT-293987 (NS-304)[1] Selexipag[1] D09994 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86